Sponsors developing drugs for CNS or CV indications may rely on Clinilabs to assist in planning their drug development programs. Clinilabs’ relationship with key opinion leaders are an important complement to advisory panels. These individuals bring a wealth of scientific expertise that is coupled with Clinilabs' institutional knowledge gained from the conduct of more than 170 clinical trials.
|
